老虎证券
Invest
Pricing
Rewards
Support
Learn
About
Quotes
TigerAI
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Inhibrx Biosciences, Inc.
15.86
0.0000
成交量:
- -
成交额:
1,097.66万
市值:
2.26亿
市盈率:
- -
高:
15.86
开:
15.86
低:
15.86
收:
15.86
52周最高:
15.86
52周最低:
15.86
股本:
1,424.00万
流通股本:
1,424.00万
量比:
- -
换手率:
- -
股息:
- -
股息率:
- -
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
公司资料
公司名字:
Inhibrx Biosciences, Inc.
交易所:
NASDAQ
成立时间:
- -
员工人数:
- -
公司地址:
- -
官网:
http://www.inhibrx.com
邮编:
- -
电话:
- -
传真:
- -
简介:
Inhibrx Biosciences, Inc.于2024年1月8日根据特拉华州法律成立,是Inhibrx, Inc.的直接全资子公司。该公司是一家临床阶段的生物制药公司,拥有一系列新型候选生物治疗药物,使用其专有的模块化蛋白质工程平台开发。
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎国际,美股交易,港股交易,交易美股,股票信息,股价,美股行情,美股打新,港股打新,IPO打新,购买美股,全球投资","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/INXB/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"INXB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INXB\",,,,,undefined,":{"symbol":"INXB","market":"US","secType":"STK","nameCN":"Inhibrx Biosciences, Inc.","latestPrice":15.86,"timestamp":1717099200000,"preClose":15.86,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":14240000,"shares":14240000,"eps":0,"marketStatus":"休市中","change":0,"latestTime":"05-30 16:00:00 EDT","open":15.86,"high":15.86,"low":15.86,"amount":10976590.3275,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"symbolChange":{"newSymbol":"INBX","executeDate":"2024-05-31"},"adr":0,"exchange":"NASDAQ","adjPreClose":15.86,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INXB\",,,,,undefined,":{"symbol":"INXB","floatShares":14240000,"roa":"--","roe":"--","lyrEps":0,"shares":14240000,"dividePrice":0,"high":15.86,"amplitude":0,"preClose":15.86,"low":15.86,"week52Low":15.86,"pbRate":"--","week52High":15.86,"institutionHeld":0,"latestPrice":15.86,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":15.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INXB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-31","symbol":"INXB","oldSymbol":"INXB","defaultRemindTime":1717162200000,"newSymbol":"INBX","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1717128000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INXB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INXB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1723608000000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.inhibrx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inhibrx Biosciences, Inc.于2024年1月8日根据特拉华州法律成立,是Inhibrx, Inc.的直接全资子公司。该公司是一家临床阶段的生物制药公司,拥有一系列新型候选生物治疗药物,使用其专有的模块化蛋白质工程平台开发。","exchange":"NASDAQ","name":"Inhibrx Biosciences, Inc.","nameEN":"Inhibrx Biosciences, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"INXB\",market:\"US\",,,undefined,":null}}